Eledon Pharmaceuticals, Inc. — 8-K Filings
113 8-K filings on record
This page lists all 8-K filings submitted to the SEC by Eledon Pharmaceuticals, Inc. (ELDN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Eledon Pharmaceuticals, Inc. has filed 113 8-K documents with the SEC since 2007. To view all SEC filings by Eledon Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
424B2
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
EFFECT
FWP
IRANNOTICE
NT 10-Q
PRE 14A
PREM14A
PRER14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-26-116154 | Mar 19, 2026 | — |
| 8-K | 8-K | 0001193125-26-000968 | Jan 2, 2026 | Dec 30, 2025 |
| 8-K | 8-K | 0001193125-25-283294 | Nov 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-278392 | Nov 13, 2025 | Nov 12, 2025 |
| 8-K | 8-K | 0001193125-25-270286 | Nov 7, 2025 | Nov 6, 2025 |
| 8-K | 8-K | 0001193125-25-180820 | Aug 14, 2025 | Aug 11, 2025 |
| 8-K | 8-K | 0000950170-25-103975 | Aug 6, 2025 | — |
| 8-K | 8-K | 0000950170-25-085588 | Jun 12, 2025 | Jun 10, 2025 |
| 8-K | 8-K | 0000950170-25-071370 | May 14, 2025 | — |
| 8-K | 8-K | 0000950170-25-051663 | Apr 7, 2025 | Apr 1, 2025 |
| 8-K | 8-K | 0000950170-25-042644 | Mar 20, 2025 | — |
| 8-K | 8-K | 0000950170-24-138782 | Dec 20, 2024 | Dec 16, 2024 |
| 8-K | 8-K | 0000950170-24-125340 | Nov 12, 2024 | — |
| 8-K | 8-K | 0000950170-24-118497 | Oct 30, 2024 | Oct 29, 2024 |
| 8-K | 8-K | 0000950170-24-117946 | Oct 29, 2024 | — |
| 8-K | 8-K | 0000950170-24-110857 | Oct 1, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0000950170-24-108465 | Sep 20, 2024 | — |
| 8-K | 8-K | 0000950170-24-097206 | Aug 14, 2024 | Aug 13, 2024 |
| 8-K | 8-K | 0000950170-24-083220 | Jul 12, 2024 | Jul 10, 2024 |
| 8-K | 8-K | 0000950170-24-082730 | Jul 10, 2024 | — |
| 8-K | 8-K | 0000950170-24-082739 | Jul 10, 2024 | Jul 8, 2024 |
| 8-K | 8-K | 0000950170-24-058706 | May 13, 2024 | May 9, 2024 |
| 8-K | 8-K | 0000950170-24-053934 | May 7, 2024 | May 6, 2024 |
| 8-K | 8-K | 0000950170-24-038008 | Mar 28, 2024 | — |
| 8-K | 8-K | 0000950170-23-062007 | Nov 9, 2023 | — |
| 8-K | 8-K | 0000950170-23-058279 | Nov 2, 2023 | — |
| 8-K | 8-K | 0000950170-23-050925 | Oct 2, 2023 | Sep 29, 2023 |
| 8-K | 8-K | 0000950170-23-049046 | Sep 21, 2023 | Sep 20, 2023 |
| 8-K | 8-K | 0000950170-23-047951 | Sep 13, 2023 | Sep 11, 2023 |
| 8-K | 8-K | 0000950170-23-040949 | Aug 10, 2023 | — |
| 8-K | 8-K | 0000950170-23-029259 | Jun 22, 2023 | Jun 21, 2023 |
| 8-K | 8-K | 0000950170-23-021198 | May 11, 2023 | — |
| 8-K | 8-K | 0000950170-23-016017 | May 1, 2023 | Apr 26, 2023 |
| 8-K | 8-K | 0000950170-23-010924 | Mar 30, 2023 | — |
| 8-K | 8-K | 0000950170-23-000465 | Jan 9, 2023 | — |
| 8-K | 8-K | 0000950170-22-024980 | Nov 14, 2022 | — |
| 8-K | 8-K | 0000950170-22-016850 | Aug 11, 2022 | — |
| 8-K | 8-K | 0000950170-22-011978 | Jun 23, 2022 | Jun 22, 2022 |
| 8-K | 8-K | 0000950170-22-010890 | May 31, 2022 | — |
| 8-K | 8-K 2022 Q1 | 0001564590-22-019851 | May 12, 2022 | — |
| 8-K | 8-K | 0001564590-22-011680 | Mar 24, 2022 | — |
| 8-K | 8-K FOR BVF COMMON SHARE EXCHANGE AGREEMENT | 0001564590-22-001203 | Jan 13, 2022 | Jan 11, 2022 |
| 8-K | 8-K FOR Q3'21 EARNINGS RELEASE | 0001564590-21-056413 | Nov 12, 2021 | — |
| 8-K | 8-K | 0001564590-21-043944 | Aug 12, 2021 | — |
| 8-K | 8-K | 0001564590-21-039644 | Aug 2, 2021 | Jul 31, 2021 |
| 8-K | 8-K | 0001564590-21-035584 | Jul 2, 2021 | Jul 1, 2021 |
| 8-K | 8-K | 0001564590-21-033187 | Jun 16, 2021 | Jun 15, 2021 |
| 8-K | 8-K | 0001564590-21-027581 | May 13, 2021 | — |
| 8-K | 8-K | 0001564590-21-020624 | Apr 27, 2021 | Apr 26, 2021 |
| 8-K | 8-K | 0001564590-21-013094 | Mar 15, 2021 | — |